Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06004882
Other study ID # 2023-0041
Secondary ID NCI-2023-06513
Status Recruiting
Phase N/A
First received
Last updated
Start date August 10, 2023
Est. completion date January 31, 2026

Study information

Verified date May 2024
Source M.D. Anderson Cancer Center
Contact Saba Javed, MD
Phone (713) 792-9530
Email sjaved@mdanderson.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the effects of the following types of therapy on knee range of motion when given to patients with chronic knee pain: - A standard steroid injection - Peripheral nerve stimulation (PNS) therapy in combination with a standard steroid injection - PNS therapy in combination with a placebo injection Steroid injections are given directly into the knee joints and are considered to be the standard therapy for chronic knee pain. In this study, the injection will be made of the steroid drugs triamcinolone and bupivacaine.


Description:

Primary Objectives: - To compare the mean change in knee range of motion using goniometry from at 30 days (visit 2) from baseline among the three treatment arms. Secondary Objectives: - To compare the mean change in knee range of motion using goniometry at 60 days (visit 3) and 90 days (visit 4) from baseline among the three treatment arms. - To compare changes in knee pain scores (NRS), WOMAC index, use of opioids (measured in morphine milliequivalent), and incidence of complications and adverse effects at 30 days, 60 days, and 90 days from baseline among the three treatment arms


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date January 31, 2026
Est. primary completion date January 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients diagnosed with chronic knee pain (baseline pain score >=4), seen at Pain Management Center at MD Anderson Cancer Center; if patient has bilateral knee pain, the side with the more severe knee pain will be treated first and counted towards the primary and secondary endpoints - Patients between ages 18-85 years old - Patient signed informed consent Exclusion Criteria: - Patients with cognitive dysfunction or without capacity to consent - Patient with recent history (<6 months) of drug or alcohol abuse - Patients with open skin lesion or undergoing antibiotic therapy for local for systemic infection - Patients with allergies to local anesthesia, steroids, or adhesives - Patients who are on opioids for reasons other than knee pain

Study Design


Related Conditions & MeSH terms


Intervention

Other:
PNS therapy
PNS therapy-NS is a 60-day therapy targeting chronic pain. The procedure involves implanting a small piece of wire next to the nerve causing pain, and the wire is connected to an external device that is then used to apply electric pulses to the nerve, blocking pain signals, for 60 days
Drug:
Triamcinolone
Given by Injection
Bupivacaine
Given by Injection
Other:
Placebo
Given by Injection

Locations

Country Name City State
United States M D Anderson Cancer Center Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 4.0 through study completion; an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05920382 - Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. N/A
Active, not recruiting NCT06340035 - Percutaneous Peripheral Nerve Stimulation of Gluteus Nerves to Improve Hip Strength and Power N/A
Recruiting NCT05473663 - Radiofrequency Ablation After Total Knee Arthroplasty N/A
Withdrawn NCT05335486 - Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain Phase 2/Phase 3
Completed NCT05031104 - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis N/A
Not yet recruiting NCT06000709 - Comparison Between Ultrasound-Guided Genicular Nerve Phenol Neurolysis and Intra-articular Steroid Injections Phase 4
Completed NCT05003323 - Brain Biomarker of Endogenous Analgesia in Patients With Chronic Knee Pain
Recruiting NCT04580732 - Clinical Trial of the MiniStim PNS for Knee Pain- "FLEX" Study N/A
Terminated NCT04601168 - Assessment of the Safety and Performance of a Compression Knee Support in the Prevention of Injuries During Sports Practice
Completed NCT01977872 - JointADventure: A Worksite Activity-Diet Intervention for Chronic Knee Pain N/A
Recruiting NCT05407610 - Comparison of Conventional and Cooled Radiofrequency of the Genicular Nerves in Patients With Chronic Knee Pain N/A
Recruiting NCT05816798 - Photobiomodulation in Chronic Knee Pain in Patients Who Are in PreRehabilitation for Bariatric Surgery Phase 2/Phase 3
Terminated NCT04275128 - Cooled Versus Conventional Genicular Radiofrequency Ablation for Chronic Knee Pain
Completed NCT04234984 - Patients With Chronic Knee Pain Treated With Conventional Radiofrequency of the Genicular Nerves
Completed NCT05315934 - Comparing the Effects of Upper and Lower Body Aerobic Exercise on Pain in Individuals With Chronic Knee Pain N/A
Completed NCT02931435 - Radiofrequency For Chronic Knee Pain Post-Arthroplasty N/A
Completed NCT05137080 - Dexamethasone and Functional Outcome After TKA Phase 4
Not yet recruiting NCT06133738 - Effects of iCBT and Exercise for Chronic Knee Patients N/A
Recruiting NCT05251142 - Plyometric Training in Volleyball Players With Chronic Knee Pain N/A

External Links